RDx Bioscience, CEO settle kickback case for $13M
By 
Adrianne Appel2024-01-11T21:50:00
A New Jersey-based clinical laboratory and its chief executive officer agreed to pay more than $13 million to the Department of Justice (DOJ) to settle illegal kickback allegations.
RDx Bioscience and CEO Eric Leykin engaged in a scheme, between 2017 and 2023, to pay five different types of kickbacks designed to induce referrals for lab testing, the DOJ alleged in its settlement agreement published Wednesday.
Under the agreement, RDx and Leykin will pay approximately $10.3 million to the DOJ and $2.9 million to New Jersey, for portions of alleged false claims made to the state’s Medicaid program.
Related articles
-
News BriefLawsuit: Ex-Panoramic Health assistant GC alleges retaliation linked to CCO supervisor
The former assistant general counsel at Panoramic Health is suing her former employer alleging wrongful termination after flagging safe harbor violations of the Anti-Kickback Statue.
-
News Brief
Atlantic Home Health Care to pay $10M over energy program false claims
Atlantic Home Health Care LLC agreed to pay nearly $10 million as part of a settlement with the Department of Justice addressing the alleged submission of false claims to the Department of Labor’s Energy Employees Occupational Illness Compensation Program.
-
News BriefNursing home chain, owner to pay $45.6M in kickbacks case
Prema Thekkek and the six skilled nursing homes she owned through her company, Paksn, agreed to pay $45.6 million in entering a consent judgment with the Department of Justice to resolve allegations employees paid kickbacks to doctors who brought patients to them.
More from Regulatory Enforcement
-
News BriefSEC reportedly investigating MassMutual’s accounting amid ongoing government shutdown
Even though the U.S. federal government is currently shut down, the U.S. Securities and Exchange Commission appears to still be at work. The financial regulator is reportedly investigating a major insurance and asset management company over its accounting practices.
-
News BriefAMLA: What difference will the agency make in the EU’s fight against moneylaundering?
Europe’s massive financial sector has become a magnet for illicit money flowing through its banks and markets. A new EU agency will be taking the problem head-on to fight against money laundering.
-
ArticleFormer startup CEO gets 7 years in prison for $175M fraud against JPMorgan Chase
Charlie Javice, a former CEO who duped JPMorgan Chase into purchasing her start up company for $175 million, has been ordered to forfeit more than $22 million by the Department of Justice (DOJ) and to spend 7 years in jail.